(1) Rassart É, Bedirian A, Do Carmo S, Guinard O, Sirois J, Terrisse L, Milne R. Apolipoprotein D. Biochim Biophys Acta 2000; 1482: 185-198. (2) Smith KM, Lawn RM, Wilcox JN. Cellular localization of apolipoprotein D and lecithin: cholesterol acyltransferase mRNA in rhesus monkey tissues by in situ hybridization. J Lipids Res 1990; 31: 995-1004. (3) Boyles JK, Notterpek LM, Wardell MR, Rall SC Jr. Identification, characterization and tissue distribution of apolipoprotein D in the rat. J Lipids Res 1990; 31: 2057-2065. (4) Provost PR, Weech PK, Tremblay NM, Marcel YL, Rassart E. Molecular characterization and differential mRNA tissue distribution of rabbit apolipoprotein D. J Lipids Res 1990; 31: 2057-2065. (5) Séguin D, Deforges M, Rassart E. Molecular characterization and differential mRNA tissue distribution of mouse apolipoprotein D. Mol Brain Res 1995; 30: 242-250. (6) Patel SC, Asotra KA, Patel YC, McConathy WJ, Patel RC, Suresh S. Astrocytes synthesize and secrete the lipophilic ligand carrier apolipoprotein D. Neuro Report 1995; 6: 653-657. (7) Navarro A, Tolivia J, Astudillo A, del Valle E. Pattern of apolipoprotein D immunoreactivity in human brain. Neurosci Lett 1998, 254: 17-20. (8) Glomset JA, Norum KR. The metabolic role of lecithin-cholesterol acyltransferase: perspectives from pathology. Adv Lipid Res 1973; 11: 1-65. (9) Spreyer P, Schaal H, Kuhn G, Rothe T, Unterbeck A, Olek K, Müller HW. Regeneration-associated high level expression of apolipoprotein D mRNA in endoneurial fibroblast of peripheral nerve. Eur Mol Biol Org J 1990; 9: 2479-2484. (10) Suresh, S.; Yan, Z.; Patel, RC.; Patel, YC.; Patel, SC. Cellular cholesterol storage in the Niemann-Pick disease type C Mouse is associated with increased expression and defective processing of apolipoprotein D. J. Neurochem., (1998), 70: 242-251. (11) Terrisse L, Poirier J, Bertrand P, Merched A, Visvikis S, Siest G, Milne R, Rassart É.(1998) Increased levels of apolipoprotein D in cerebrospinal fluid and hippocampus of Alzheimer’s patients. J Neurochem 71: 1643-1650. (12) Thomas EA, Dean B, Pavey G, Sutcliffe JG. Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders. Proc Natl Acad Sci U.S.A. 2001; 98: 4066-4071. (13) Ong WY, He Y, Suresh S, Patel SC. Differential expression of apolipoprotein D and apolipoprotein E in the kainic acid-lesioned rat hippocampus. Neuroscience 1997; 79: 359-67. (14) Terrise L, Séguin D, Bertrand P, Poirier J, Milne R, Rassart E. Modulation of apolipoprotein D and apolipoprotein E expression in rat hippocampus after entorhinal cortex lesion. Mol Brain Res. 1999; 70: 26-35. (15) Ollanow CW, Youdim MB. Neurodegeneration and neuroprotection in Parkinson´s disease. New York: Academic Press, 1996. (16) Schapira AH. Pathogenesis of Parkinson´s disease. Ballieres Clin Neurol 1997; 6: 15-36. (17) Relton, JK; Strijbos, PJ; Cooper, AL; Rothwell, NJ. 1993. Dietary N-3 fatty acids inhibit ischaemic and excitotoxic brain damage in the rat. (18) Bazan, NG; Rodríguez de Turoco, EB; Allang, G. Mediators of injury in neurotrauma: intracellular signal transduction and gene expression. J. Neurotrauma 1995; 12: 791-814. (19) Shing, JK, Dasgupta, A., Adayev, T., Shahmehdi, SA., Hammond, D., Banerjee, P. Apoptosis is associated with an increase in saturated fatty acid containing phospholipids in neuronal cell line HN2-5. Biochem Biophys Acta 1996; 1304: 171-178. (20) Kruman, I; Bruce-Keller, AJ; Bredesen, D; Waeg, G; Mattson, MP. Evidence that 4-hydroxynomenal mediates oxidate stress-induced neuronal apoptosis. J Neurosci 1997; 17: 5089-5100. (21)Chapman, A., Ingvar, M., Siejo, BK. Free fatty acid in brain in bicuculline-induced SE. Acta Physiol Scand 1980; 110: 335-336. (22) Zhang, JP., Sun, GY. Free fatty acid, neutral glycerides and phosphoglycerides in transient focal cerebral ischemia. J. Neurochem 1995; 64: 1688-1695. (23) Holtsberg, FW; Steiner, MR; Keller, JN; Marck, RJ; Mattson, MP; Steiner, SM. Lysophosphatidic acid induces necrosis and apoptosis in hippocampal neurons. J Neurochem 1998; 70: 66-76. (24) Kivatinitz, SC; Pelsman, MA; Alonso, AC; Bagatolli, L; Quiroga, S. High-density lipoprotein aggregated by oxidation induces degeneration of neuronal cells. J Neurochem 1997; 69: 2102-2114. (25) Thomas EA, George RC, Sutcliffe JG. Apolipoprotein D modulates arachidonic acid signaling in cultured cells: implications for psychiatric disorders. Prostaglandins Leukot Essent Fatty Acids 2003; 69(6):421-7. (26) Yoritaka A, Hattori N, Mori H, Kato K, Mizuno Y. An immunohistochemical study on manganese superoxide dismutase in Parkinson's disease. J Neurol Sci 1997; 148(2):181-6. (27) Ebadi M, Srinivasan SK, Baxi MD. Oxidative stress and antioxidant therapy in Parkinson's disease. Prog Neurobiol 1996;48(1):1-19. (28) Kalman J, McConathy W, Araoz C, Kasa P, Lacko AG. Apolipoprotein D in the aging brain and in Alzheimer's dementia. Neurol Res 2000; 22(4):330-6. (29) Khan MM, Parikh VV, Mahadik SP. Antipsychotic drugs differentially modulate apolipoprotein D in rat brain. J Neurochem 2003;86(5):1089-
|